Articles tagged with Type 1 Diabetes
Research suggests that physical exercise preserves beta cell function, reducing complications and improving blood sugar control. However, large-scale trials are necessary to confirm the benefits of exercise in slowing the onset of type 1 diabetes in children and adults.
A new study published in Diabetologia found that children infected with enterovirus were 48% more likely to develop type 1 diabetes. The study's results suggest a positive correlation between EV infection and the incidence of type 1 diabetes, which may be driven by environmental factors in regions with high EV prevalence.
Researchers at Harvard University have made a breakthrough in producing human insulin-producing beta cells equivalent to normally functioning cells, offering hope for new diabetes treatment. The development involves massive quantities of human embryonic stem cells and could lead to drug discovery and transplantation therapy.
A study of 37,539 children and young adults with type 1 diabetes found that the link between low average glucose blood levels and severe hypoglycemia declined substantially between 1995 and 2012. The relative risk for severe hypoglycemia decreased from 1.28 to 1.05 per 1% decrease in HbA1c levels, corresponding to a drop in risk of 1.2...
A recent study from Tel Aviv University suggests that prenatal exposure to viruses may cause type 1 diabetes and other autoimmune diseases in children. The researchers found a link between winter epidemics and increased levels of damaging antibodies in cord blood, indicating autoimmune damage to islet cells during gestation.
Researchers at UC San Diego aim to bioengineer the irregularly shaped patches of the pancreas called Islets of Langerhans in a dish. This could lead to studying the events that trigger beta cell destruction and developing new drug therapies, as well as understanding the genetic component of the disease.
Researchers have discovered a new mechanism for inhibiting the immunoproteasome, a protein complex involved in autoimmune disorders such as rheumatism and multiple sclerosis. The found mechanism involves a novel compound that selectively targets and deactivates the immunoproteasome without affecting other proteasomes.
A nationwide study of over 18,000 patients with type 1 diabetes found that insulin pump treatment reduces all-cause mortality by 29% and fatal cardiovascular disease risk by 43%. Pump use was also associated with an 18% risk reduction for coronary heart disease.
A new model predicts which type 1 diabetes patients will develop major complications, such as coronary heart disease and blindness. The model uses easily measurable risk factors, allowing healthcare professionals to identify high-risk patients and implement preventative strategies.
Researchers found that closed-loop insulin delivery systems maintained safe blood glucose levels for 53-82% of the time. The study proposed improvements needed for better design and implementation of these systems in adults and adolescents with type 1 diabetes.
The University of Chicago Medicine and Advocate Children's Hospital have received a $1.8 million NIH grant to establish the first Type 1 Diabetes TrialNet Clinical Center in Chicago. The center aims to identify people at risk or early stages of type 1 diabetes through international collaboration.
Researchers at Sanford Burnham Prebys Institute have discovered a promising technique to restore insulin production in people with Type 1 diabetes. A peptide called caerulein was found to convert existing alpha cells into insulin-producing beta cells, potentially freeing patients from daily insulin doses.
Researchers discovered that mice born by natural birth have a stronger immune system due to exposure to their mother's beneficial bacteria. This may lead to the development of autoimmune diseases such as type 1 diabetes and Crohn's disease.
Researchers have identified genetic markers that can predict the development of celiac disease in infants. The study found a significantly higher risk for celiac disease among Swedish children compared to their European counterparts.
A recent NIH-funded study found that children with two copies of a high-risk variant in specific genes have a 26% chance of developing early signs of celiac disease by age 5. The study also revealed higher rates of celiac disease in Sweden compared to the US and other European countries.
Researchers found that high blood glucose levels increase neurotransmitter associated with depression and alter brain connections in patients with Type 1 diabetes. The study suggests a biological mechanism for the increased risk of depression in these individuals.
A new survey reveals that nearly 70% of adults with Type 1 diabetes do not use their blood glucose self-monitoring devices or insulin pumps to download historical data about their blood sugar levels and insulin doses. Only 12% of patients regularly review their past glucose and insulin pump data at home.
A recent gene study has identified a novel biological pathway that affects insulin release in type 1 diabetes. The Clec16a gene plays a critical role in regulating insulin metabolism and acts upon a pathway crucial to insulin secretion.
A genetic risk component of type 1 diabetes has been shed light on by a study identifying the role of gene Clec16a in faulty cell recycling. Healthy mitochondria are crucial to insulin production and blood sugar control, making this finding a significant step towards treating or preventing both type 1 and type 2 diabetes.
Researchers found that interventions for diabetes distress significantly reduced symptoms of depression in people with type 2 diabetes. In contrast, patients with type 1 diabetes who reported high levels of depressive symptoms had a higher mortality risk. These findings suggest that 'diabetes distress' may not be a co-morbid psychiatri...
A worldwide study by Georgia State University found no link between baby formula consumption and diabetes-associated autoantibodies. The TRIGR study tracked children genetically predisposed to type 1 diabetes for seven years, revealing a lack of correlation between cow's milk protein and autoantibody development.
The American Diabetes Association lowers its target recommendation for blood glucose levels in children with type 1 diabetes to lower than 7.5 percent, reflecting research showing prolonged hyperglycemia can lead to early development of serious complications such as cardiovascular disease and kidney disease.
Researchers found that the bionic pancreas reduced interventions for low blood glucose by 37% and improved glucose levels, particularly at night. The device also showed a more than twofold reduction in hypoglycemia time in both adults and adolescents.
Researchers at the University of Cincinnati have discovered a therapy that reverses new onset Type 1 diabetes in mouse models. The treatment targets the innate immune system and boosts activity of TLR4, preserving insulin-producing beta cells. This approach may hold promise for treating Type 1 diabetes in humans.
Research reveals distinct differences in gut microbiota between young children with and without type 1 diabetes. The study, published in Diabetologia, found that diabetic children have an imbalanced gut microbiome, while healthy controls exhibit a balanced balance of beneficial bacteria.
A large-scale study of over 2,100 infants found that delaying exposure to complex foreign proteins in cow's milk does not reduce the risk of developing type 1 diabetes. The study, led by Professor Mikael Knip, explored whether an early dietary modification could affect the disease process.
A study of 2,070 children found no association between hydrolyzed formulas and reduced risk of beta-cell autoimmunity in infancy. The use of hydrolyzed formulas during infancy did not reduce the incidence of diabetes-associated autoantibodies after 7 years.
A new study published in PNAS reveals how the GAD65 protein changes shape when activated, potentially linking it to type 1 diabetes. The research found that antibodies interact with the protein differently depending on its state, which may affect vaccine development for the disease.
A long-term observational study found that people with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic levels over the long term. Those who lowered their HbA1C levels demonstrated a significantly lower risk of end-stage renal disease after a ...
A new study on mice found that mothers eating a gluten-free diet during pregnancy and lactation can protect their pups from developing type 1 diabetes. The researchers hope that this knowledge can be used to develop new treatments for the disease, which affects over 1% of the Danish population.
Researchers found significant increases in type 1 and 2 diabetes among US youth, with a 21% rise in type 1 diabetes and a 30.5% increase in type 2 diabetes between 2001 and 2009. The prevalence of both types increased across all racial/ethnic groups and age groups.
Joslin Medalists with type 1 diabetes for 50+ years have higher levels of endothelial progenitor cells (EPCs) and circulating progenitor cells (CPCs), associated with lower cardiovascular and kidney disease. These findings suggest that measuring CPC levels may help identify people at risk for complications.
Research published in Diabetologia suggests Sweden may have 2-3 times more adolescents and young adults with type 1 diabetes than estimated. The study used a new method to estimate incidence rates among young people, finding a significant disparity between previous estimates.
A recent study found that DKA rates among US youth with type 1 diabetes remained unchanged over the last 8 years, affecting nearly a third of all youth with the condition. The study also showed disproportionate rates among younger children, non-White racial/ethnic groups, and those without private health insurance.
Researchers found that rotavirus infection activates specific immune cells, including dendritic cells and T cells, which can recognize and destroy insulin-producing islet cells. This 'bystander activation' contributes to the acceleration of autoimmune diabetes in a mouse model.
Researchers found that rotavirus infection accelerates type 1 diabetes development through a bystander effect, where the immune system attacks insulin-producing cells. The study suggests that treatments targeting this immune response could be beneficial for preventing type 1 diabetes in children at risk.
The University of Colorado will receive a $2.1 million grant to help adolescents with Type 1 diabetes manage their disease and improve health outcomes through the Flexible Lifestyle 3mpowering Change (FL3X) study. The study aims to teach teens how to manage insulin, blood sugar, and daily tasks, with positive outcomes from a pilot study.
A study of 44 middle-age adults with Type 1 diabetes found that those diagnosed at older ages had weaker brain connectivity compared to those diagnosed earlier. The researchers suggest that further study is needed to understand the impact of early diagnosis on brain function and development.
Researchers found that gut microbiota diversity and interaction networks vary significantly between children with and without autoantibodies, influencing the body's immune system. The study suggests that identifying parameters affecting negative microbiome characteristics can lead to new approaches in preventing autoimmune processes.
Researchers at Helmholtz Munich have found that GAD antibody affinity is a key indicator of LADA disease progression. The study used GAD vaccination to examine the impact on antibody affinity in 46 LADA patients, finding no influence from vaccination. Patients with high affinity had low insulin production and required insulin therapy s...
Researchers found that children with prediabetes and multiple islet autoantibodies had lower vitamin D levels, which increased during summer months. Vitamin D supplementation may be recommended at an early stage to prevent deficiency.
A new study found that individuals with a history of hypoglycemia are more likely to experience recurrent episodes when using an automatic insulin pump. The ASPIRE study suggests that the 'threshold suspend' feature may not be effective in preventing subsequent events.
Lund University researchers have created a method to visualize inflammatory processes in the pancreas during type 1 diabetes. This allows them to study the body's response to new treatment strategies and potentially develop a model for human immune system diseases.
Researchers found that skin cells from people with type 1 diabetes display elevated calcium levels when exposed to cytokines or fat, suggesting a link between environmental stimuli and genetic predisposition. This discovery may help identify susceptible individuals before disease onset.
A new study, funded by the NIH, will investigate whether reducing uric acid levels can slow down kidney function decline in people with type 1 diabetes. The research aims to find an additional safe and inexpensive way to prevent or delay kidney failure.
Researchers have discovered that a cancer drug can protect the insulin-producing cells in the pancreas and prevent the development of type 1 diabetes in mice. The medication works by reducing sterile inflammation and delaying cell destruction. This finding is a step towards developing a preventive treatment for type 1 diabetes.
Professor Len Harrison has been awarded the JDRF Australia Lifetime Research Achievement Award for his groundbreaking work on improving treatments for people with type 1 diabetes. His research aims to prevent or delay the onset of the disease, bringing hope for better therapies and treatments.
Research published in Diabetologia shows that pre-existing diabetes in pregnant women significantly increases the risk of fetal and infant death. The study found a four-and-a-half times higher risk of fetal death and an almost doubling of infant mortality compared to women without diabetes.
Researchers have identified adolescents with type 1 diabetes at risk of developing heart and kidney diseases through a simple urine test. The study found that normal variation in albumin levels can be an indicator of risk during adolescence.
New technology enabled scientists to prove that most people with type 1 diabetes have active beta cells producing insulin in response to food, contrary to previous thought. This finding has significant implications for understanding the biology of Type 1 diabetes and may lead to new therapies to preserve or replenish beta cells.
Joslin researchers found T cells, not B cells, contribute to beta cell proliferation in type 1 diabetes. Immune cells secrete inflammatory cytokines and chemokines that enhance beta cell growth.
The Joslin Diabetes Center will conduct a clinical trial to evaluate the benefits of allopurinol in reducing kidney function loss among people with type 1 diabetes. The five-year trial aims to determine if high serum uric acid levels are the cause of diabetic kidney disease.
A UK study found improved life expectancy for people with type 1 diabetes, particularly among younger individuals. The research suggests that this improvement should be reflected in life insurance policies, but gaps in life expectancy remain between the T1DM population and general populations.
A study of 1038 patients with type 1 diabetes reveals that social deprivation and poor blood sugar control are independent risk factors for mortality. Those with higher HbA1c levels and lower socioeconomic status were more likely to die from complications related to the disease.
The study found that sensor-augmented pump therapy significantly reduced the rate of severe and moderate hypoglycemia among patients with type 1 diabetes, particularly those with impaired awareness. The technology demonstrated potential to reduce the duration and frequency of significant hypoglycemia.
Research published at EASD annual meeting shows having children lowers mortality in people with type 1 diabetes, particularly for women. Mortality rates are significantly higher among women with diabetes compared to controls, but having offspring reduces this disparity.
A large European study suggests men with type 1 diabetes have better blood sugar control than women, especially in older age groups. Women tend to have higher HbA1c levels due to lower hemoglobin levels, which could explain the difference.
Researchers found that alefacept preserved the body's ability to produce its own insulin, with fewer episodes of hypoglycemia, while selectively targeting disease-causing T cells. The study suggests a potential new strategy for treating type 1 diabetes by restoring balance between immune cells.
A phase II study found that alefacept treatment significantly reduced insulin use and hypoglycemic events in newly diagnosed type 1 diabetics. The therapy targeted memory T-cells, preserving regulatory T-cells.
The new procedure, known as the CIT07 protocol, resulted in significantly improved islet cell function and enabled patients to discontinue daily insulin injections. The approach reduced inflammation and allowed for more efficient use of fewer islet cells.